Today news
The same in other media
Targeting early brain inflammation may slow down Alzheimer’s
Reading now: 937
Research in animal models suggests rebalancing early brain inflammation may slow the progression of Alzheimer’s disease. The new study was on the agenda of the American Association for Anatomy (AAA) annual meeting prior to its cancellation because of the COVID-19 pandemic.
The research makes clear an area for future investigation that may help scientists develop early interventions to counter the progression of Alzheimer’s.
The abstract for the study now appears in The Journal of the Federation of American Societies for Experimental Biology. According to the Centres for Disease Control and Prevention (CDC), Alzheimer’s disease is a neurodegenerative disease that impacts a person’s brain.
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
COVID-19
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|